Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis

Author:

Collier Philip N.1ORCID,Twin Heather C.,Knegtel Ronald M. A.ORCID,Boyall Dean,Brenchley Guy,Davis Christopher J.,Keily Shazia,Mak Chau,Miller Andrew,Pierard Françoise,Settimo Luca,Bolton Clare M.,Chiu Peter,Curnock Adam,Doyle Elisabeth1,Tanner Adam J.,Jimenez Juan-Miguel

Affiliation:

1. Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, Massachusetts 02210, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Discovery of a novel series of selective macrocyclic PKCTheta inhibitors;Bioorganic & Medicinal Chemistry Letters;2024-03

2. Recent advances in the synthesis of 3,3-disubstituted oxetanes;Advances in Heterocyclic Chemistry;2024

3. Applications of oxetanes in drug discovery and medicinal chemistry;European Journal of Medicinal Chemistry;2023-12

4. Oxetanes in Drug Discovery Campaigns;Journal of Medicinal Chemistry;2023-09-07

5. Fused Pyridine Derivatives: Synthesis and Biological Activities;Exploring Chemistry with Pyridine Derivatives;2023-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3